Publicaciones en colaboración con investigadoras/es de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (8)

2023

  1. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 5

2022

  1. Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

2020

  1. Nanostructured lipid carriers made of Ω-3 polyunsaturated fatty acids: In vitro evaluation of emerging nanocarriers to treat neurodegenerative diseases

    Pharmaceutics, Vol. 12, Núm. 10, pp. 1-22

2019

  1. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

    Neurobiology of Disease, Vol. 121, pp. 252-262

2018

  1. Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 145-155

  2. The role of lipid nanoparticles and its surface modification in reaching the brain: An approach for neurodegenerative diseases treatment

    Current Drug Delivery, Vol. 15, Núm. 9, pp. 1218-1220

2017

  1. Nanotechnology based approaches for neurodegenerative disorders: Diagnosis and treatment

    Drug and Gene Delivery to the Central Nervous System for Neuroprotection: Nanotechnological Advances (Springer International Publishing), pp. 57-87

2016

  1. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

    Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285